1.Development and application of an optimized focus-forming assay for quantitation of influenza A virus titer
Jia LI ; Qiaohong CHU ; Lingfang ZHANG ; Xuchang SHAN ; Tangqi WANG ; Ruiwen HAN ; Yujie JIANG ; Donghong WANG ; Baoying HUANG ; Yao DENG ; Wenjie TAN
Chinese Journal of Microbiology and Immunology 2025;45(1):45-52
Objective:To establish and optimize a novel method, focus forming assay (FFA), for quantitation of influenza A virus (FluA) and compare its application performance with traditional plague forming assay (PFA).Methods:The foci chromogenic effects of three peroxidase substrates in immunostaining were compared. The PFA and FFA methods were used to explore FluA incubation times and plaque morphology on 12-well plates, and to determine optimal incubation times and virus adsorption volumes for different FluA subtypes on 96-well plates. The correlation between FFA and PFA was evaluated, and the optimized FFA was applied to the in vitro antiviral efficacy analysis of Favipiravir and neutralization test against different subtypes of FluA. Results:TRUEBLUE substrate was identified as the optimal substrate for foci visualization. Compared with the PFA, the FFA showed improved sensitivity and reduced detection time in FluA titration, and good correlation was shown between the two methods′ results. By replacing the 96-well plate with the 12-well plate for FFA titration of different subtypes of FluA, the detection time was shortened, and the amount of serum samples used could be further reduced by optimizing the virus adsorption volume. The half-maximal effective concentration of favipiravir against influenza viruses assessed by the FFA and PFA methods showed no significant difference, and was consistent with the results obtained from quantitative PCR. Additionally, the focus reduction neutralization test and hemagglutination inhibition assays demonstrated strong correlation in determining antibody titers against FluA in serum neutralization assays.Conclusions:The improved FFA method developed here provides a more efficient experimental tool for FluA titration, antiviral drug screening and broad-spectrum vaccine evaluation.
2.Relationship between depression and sexual drug use in men who have sex with men in Chengdu
Ruiwen LIU ; Yang ZHU ; Bo ZHANG ; Xiaoting CHEN ; Chun HAO ; Jing GU ; Jinghua LI ; Wangnan CAO ; Fengsu HOU
Chinese Journal of Epidemiology 2025;46(3):462-468
Objective:To investigate the prevalence of sexual drug use in men who have sex with men (MSM) in Chengdu and analyze the relationship between depression and sexual drug use.Methods:A total of 1 277 MSM were recruited between November 2021 and May 2022. Questionnaire was used to collect information about their demographic characteristics, depression status and sexual drug use behavior. Univariate and multivariate logistic regression models were used to analyze the relationship between depression and sexual drug use.Results:In the 1 277 MSM, assessment identified 503 mild depression cases (39.4%), 196 moderate depression cases (15.3%) and 171 severe depression cases (13.4%) and 444 MSM (34.8%) reported sexual drug use in the past 6 months. Multivariate logistic regression models showed that compared with non-depression, mild depression (a OR=1.67,95% CI:1.24-2.23), moderate depression (a OR=1.50,95% CI: 1.02-2.19) and severe depression (a OR=1.56,95% CI:1.04-2.32) were positively associated with sexual drug use. Conclusions:The prevalence of depression and sexual drug use were high in MSM in Chengdu. There was a positive correlation between depression and sexual drug use. It is necessary to pay close attention to depression and sexual drug use and conduct targeted intervention in MSM.
3.Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data
Chinese Journal of Pharmacoepidemiology 2025;34(7):734-742
Objective To investigate the efficacy,safety and influencing factors of the dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy(DN)in the real world.Methods The data of patients with DN who received dapagliflozin or empagliflozin treatment at Nanjing Drum Tower Hospital from January 2020 to December 2024 were collected.Inverse probability of treatment weighting(IPTW)was used to balance the two groups of covariates,and the glycated hemoglobin(HbA1c),fasting blood glucose(FPG),postprandial blood glucose(2hPG),urine microalbumin(mAlb),urine microalbumin/creatinine ratio(UACR),estimated glomerular filtration rate(eGFR)and uric acid(UA)level were compared between the two groups before and after 6 months of treatment,and the progress of the disease and the occurrence of adverse reactions were recorded in follow-up.The Kaplan-Meier method and Log-rank test were used to analyze disease progression,and the Logistic regression model was used to analyze the influencing factors of adverse reactions in each group.Results A total of 305 patients were included,there was no statistically significant difference in baseline between the two groups after IPTW.After treatment,the levels of HbA1c,FPG,2hPG,mAlb and UACR of the two groups decreased significantly(P<0.05).And the 2hPG,eGFR and UA levels were better in the dapagliflozin group than in the empagliflozin group(P<0.05).There was no significant difference in the adverse reaction rate of the two groups(P>0.05).The median progression-free survival time of dapagliflozin group was 47 months,which was significantly higher than that of 35 months of empagliflozin treatment(P<0.05).Multivariate analysis results showed that diabetes course over 10 years,hyperuricemia,and vitamin D deficiency are risk factors for adverse reactions in the dapagliflozin group,and the combination of uric acid-lowering drugs was the risk factor for adverse reactions in the empagliflozin group.Conclusion Compared with empagliflozin,dapagliflozin demonstrates greater advantages in delaying the progression of DN,it can significantly reduce 2hPG and UA levels,and the safety of dapagliflozin is equivalent to empagliflozin.
4.Treatments of endometrial injury diseases with integrated Traditional Chinese and Western Medicine
Xinyu ZHANG ; Shuo YANG ; Ruiwen FAN ; Dong LI ; Rong LI
Chinese Journal of Reproduction and Contraception 2025;45(9):892-895
Endometrial injury diseases are an important factors in female infertility, reduced menstruation, and adverse pregnancy outcomes. Clinical characteristics include intrauterine adhesions, a thin endometrium, and reduced endometrial receptivity. Restoring the morphology of the uterine cavity and promoting endometrial reconstruction are the main goals of treatment. At present, hormone medication and surgery are the major Western medicine treatments. Traditional Chinese Medicine has an advantage in treating endometrial injury and preventing postoperative recurrence. Traditional Chinese Medicine diagnosis focuses on "kidney deficiency" as the primary condition,"blood stasis" as the secondary condition, and combined with "liver depression". Therapeutic strategies aim to "replenish kidney""nourish blood""dispel blood stasis", and improve the endometrium. By means of combination of disease and syndrome, classical prescription addition and subtraction, clinical effective experience, combination of acupuncture and medicine and external treatment of Traditional Chinese Medicine can improve the effect and prognosis of patients with endometrial injury diseases. This article reviews the progress of combined Traditional Chinese and Western Medicine treatment of endometrial injury diseases to provide reference for its clinical treatment.
5.The predictive value of systemic immune inflammation index for pathological complete remission of triple negative breast cancer
Huan JIE ; Shirong ZHANG ; Chunna GUO ; Qiang LIU ; Danping JIANG ; Ruiwen LI ; Songbai WANG
Chinese Journal of Postgraduates of Medicine 2025;48(10):945-948
Objective:To investigate the predictive value of systemic immune inflammation index for the efficacyof neoadjuvant chemotherapy in triple negative breast cancer patients, and analyzed the relationship between pathological complete response (pCR) and prognosis.Methods:The clinical data of 146 patients with triple-negative breast cancer admitted to the 926th Hospital of the Joint Service Support Force of the PLA from January 2018 to December 2020 were retrospectively collected. All patients received neoadjuvant chemotherapy. After chemotherapy, the patients were divided into pCR group (62 cases) and non-pCR group (84 cases) according to whether the patients achieved pCR. Pathological characteristics and systemic immunoinflammatory index levels of the two groups were compared. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of systemic immunoinflammatory index for pCR after neoadjuvant chemotherapy in patients with triple-negative breast cancer, and survival curves were drawn to compare the disease-free survival of the two groups.Results:The rate of axillary lymph node metastasis in pCR group was lower than that in non-pCR group: 37.10% (23/62) vs. 64.29% (54/84), there was statistical difference ( χ2 = 10.58, P<0.01). There were no significant differences in TNM stage, Ki-67 level and histological grade between the two groups ( P>0.05). Compared with the non -pCR group, the systemic immune inflammation index in the pCR group was significantly reduced: 617.42 ± 166.40 vs. 853.67 ± 202.41, P<0.01. Systemic immune inflammation index was valuable in predicting non-pCR of triple negative breast cancer patients after neoadjuvant chemotherapy, and the area under the curve was 0.807 (95% CI: 0.738 - 0.875, P<0.01). Compared with the non-pCR group, the disease-free survival of patients in the pCR group was significantly prolonged ( P = 0.033). Conclusions:Systemic immune inflammation index was related to the efficacy of neoadjuvant chemotherapy in triple negative breast cancer patients, and can be used as a biological indicator to predict the efficacy of neoadjuvant chemotherapy in triple negative breast cancer.
6.Treatments of endometrial injury diseases with integrated Traditional Chinese and Western Medicine
Xinyu ZHANG ; Shuo YANG ; Ruiwen FAN ; Dong LI ; Rong LI
Chinese Journal of Reproduction and Contraception 2025;45(9):892-895
Endometrial injury diseases are an important factors in female infertility, reduced menstruation, and adverse pregnancy outcomes. Clinical characteristics include intrauterine adhesions, a thin endometrium, and reduced endometrial receptivity. Restoring the morphology of the uterine cavity and promoting endometrial reconstruction are the main goals of treatment. At present, hormone medication and surgery are the major Western medicine treatments. Traditional Chinese Medicine has an advantage in treating endometrial injury and preventing postoperative recurrence. Traditional Chinese Medicine diagnosis focuses on "kidney deficiency" as the primary condition,"blood stasis" as the secondary condition, and combined with "liver depression". Therapeutic strategies aim to "replenish kidney""nourish blood""dispel blood stasis", and improve the endometrium. By means of combination of disease and syndrome, classical prescription addition and subtraction, clinical effective experience, combination of acupuncture and medicine and external treatment of Traditional Chinese Medicine can improve the effect and prognosis of patients with endometrial injury diseases. This article reviews the progress of combined Traditional Chinese and Western Medicine treatment of endometrial injury diseases to provide reference for its clinical treatment.
7.Relationship between depression and sexual drug use in men who have sex with men in Chengdu
Ruiwen LIU ; Yang ZHU ; Bo ZHANG ; Xiaoting CHEN ; Chun HAO ; Jing GU ; Jinghua LI ; Wangnan CAO ; Fengsu HOU
Chinese Journal of Epidemiology 2025;46(3):462-468
Objective:To investigate the prevalence of sexual drug use in men who have sex with men (MSM) in Chengdu and analyze the relationship between depression and sexual drug use.Methods:A total of 1 277 MSM were recruited between November 2021 and May 2022. Questionnaire was used to collect information about their demographic characteristics, depression status and sexual drug use behavior. Univariate and multivariate logistic regression models were used to analyze the relationship between depression and sexual drug use.Results:In the 1 277 MSM, assessment identified 503 mild depression cases (39.4%), 196 moderate depression cases (15.3%) and 171 severe depression cases (13.4%) and 444 MSM (34.8%) reported sexual drug use in the past 6 months. Multivariate logistic regression models showed that compared with non-depression, mild depression (a OR=1.67,95% CI:1.24-2.23), moderate depression (a OR=1.50,95% CI: 1.02-2.19) and severe depression (a OR=1.56,95% CI:1.04-2.32) were positively associated with sexual drug use. Conclusions:The prevalence of depression and sexual drug use were high in MSM in Chengdu. There was a positive correlation between depression and sexual drug use. It is necessary to pay close attention to depression and sexual drug use and conduct targeted intervention in MSM.
8.Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data
Chinese Journal of Pharmacoepidemiology 2025;34(7):734-742
Objective To investigate the efficacy,safety and influencing factors of the dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy(DN)in the real world.Methods The data of patients with DN who received dapagliflozin or empagliflozin treatment at Nanjing Drum Tower Hospital from January 2020 to December 2024 were collected.Inverse probability of treatment weighting(IPTW)was used to balance the two groups of covariates,and the glycated hemoglobin(HbA1c),fasting blood glucose(FPG),postprandial blood glucose(2hPG),urine microalbumin(mAlb),urine microalbumin/creatinine ratio(UACR),estimated glomerular filtration rate(eGFR)and uric acid(UA)level were compared between the two groups before and after 6 months of treatment,and the progress of the disease and the occurrence of adverse reactions were recorded in follow-up.The Kaplan-Meier method and Log-rank test were used to analyze disease progression,and the Logistic regression model was used to analyze the influencing factors of adverse reactions in each group.Results A total of 305 patients were included,there was no statistically significant difference in baseline between the two groups after IPTW.After treatment,the levels of HbA1c,FPG,2hPG,mAlb and UACR of the two groups decreased significantly(P<0.05).And the 2hPG,eGFR and UA levels were better in the dapagliflozin group than in the empagliflozin group(P<0.05).There was no significant difference in the adverse reaction rate of the two groups(P>0.05).The median progression-free survival time of dapagliflozin group was 47 months,which was significantly higher than that of 35 months of empagliflozin treatment(P<0.05).Multivariate analysis results showed that diabetes course over 10 years,hyperuricemia,and vitamin D deficiency are risk factors for adverse reactions in the dapagliflozin group,and the combination of uric acid-lowering drugs was the risk factor for adverse reactions in the empagliflozin group.Conclusion Compared with empagliflozin,dapagliflozin demonstrates greater advantages in delaying the progression of DN,it can significantly reduce 2hPG and UA levels,and the safety of dapagliflozin is equivalent to empagliflozin.
9.The predictive value of systemic immune inflammation index for pathological complete remission of triple negative breast cancer
Huan JIE ; Shirong ZHANG ; Chunna GUO ; Qiang LIU ; Danping JIANG ; Ruiwen LI ; Songbai WANG
Chinese Journal of Postgraduates of Medicine 2025;48(10):945-948
Objective:To investigate the predictive value of systemic immune inflammation index for the efficacyof neoadjuvant chemotherapy in triple negative breast cancer patients, and analyzed the relationship between pathological complete response (pCR) and prognosis.Methods:The clinical data of 146 patients with triple-negative breast cancer admitted to the 926th Hospital of the Joint Service Support Force of the PLA from January 2018 to December 2020 were retrospectively collected. All patients received neoadjuvant chemotherapy. After chemotherapy, the patients were divided into pCR group (62 cases) and non-pCR group (84 cases) according to whether the patients achieved pCR. Pathological characteristics and systemic immunoinflammatory index levels of the two groups were compared. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of systemic immunoinflammatory index for pCR after neoadjuvant chemotherapy in patients with triple-negative breast cancer, and survival curves were drawn to compare the disease-free survival of the two groups.Results:The rate of axillary lymph node metastasis in pCR group was lower than that in non-pCR group: 37.10% (23/62) vs. 64.29% (54/84), there was statistical difference ( χ2 = 10.58, P<0.01). There were no significant differences in TNM stage, Ki-67 level and histological grade between the two groups ( P>0.05). Compared with the non -pCR group, the systemic immune inflammation index in the pCR group was significantly reduced: 617.42 ± 166.40 vs. 853.67 ± 202.41, P<0.01. Systemic immune inflammation index was valuable in predicting non-pCR of triple negative breast cancer patients after neoadjuvant chemotherapy, and the area under the curve was 0.807 (95% CI: 0.738 - 0.875, P<0.01). Compared with the non-pCR group, the disease-free survival of patients in the pCR group was significantly prolonged ( P = 0.033). Conclusions:Systemic immune inflammation index was related to the efficacy of neoadjuvant chemotherapy in triple negative breast cancer patients, and can be used as a biological indicator to predict the efficacy of neoadjuvant chemotherapy in triple negative breast cancer.
10.Development and application of an optimized focus-forming assay for quantitation of influenza A virus titer
Jia LI ; Qiaohong CHU ; Lingfang ZHANG ; Xuchang SHAN ; Tangqi WANG ; Ruiwen HAN ; Yujie JIANG ; Donghong WANG ; Baoying HUANG ; Yao DENG ; Wenjie TAN
Chinese Journal of Microbiology and Immunology 2025;45(1):45-52
Objective:To establish and optimize a novel method, focus forming assay (FFA), for quantitation of influenza A virus (FluA) and compare its application performance with traditional plague forming assay (PFA).Methods:The foci chromogenic effects of three peroxidase substrates in immunostaining were compared. The PFA and FFA methods were used to explore FluA incubation times and plaque morphology on 12-well plates, and to determine optimal incubation times and virus adsorption volumes for different FluA subtypes on 96-well plates. The correlation between FFA and PFA was evaluated, and the optimized FFA was applied to the in vitro antiviral efficacy analysis of Favipiravir and neutralization test against different subtypes of FluA. Results:TRUEBLUE substrate was identified as the optimal substrate for foci visualization. Compared with the PFA, the FFA showed improved sensitivity and reduced detection time in FluA titration, and good correlation was shown between the two methods′ results. By replacing the 96-well plate with the 12-well plate for FFA titration of different subtypes of FluA, the detection time was shortened, and the amount of serum samples used could be further reduced by optimizing the virus adsorption volume. The half-maximal effective concentration of favipiravir against influenza viruses assessed by the FFA and PFA methods showed no significant difference, and was consistent with the results obtained from quantitative PCR. Additionally, the focus reduction neutralization test and hemagglutination inhibition assays demonstrated strong correlation in determining antibody titers against FluA in serum neutralization assays.Conclusions:The improved FFA method developed here provides a more efficient experimental tool for FluA titration, antiviral drug screening and broad-spectrum vaccine evaluation.

Result Analysis
Print
Save
E-mail